Objective To use individual patient data from rheumatoid arthritis (RA) clinical trials to
identify factors that affect the response to treatment as defined by the American College of …

Objective. Therapeutic strategies for rheumatoid arthritis (RA) have been evolving from the
traditional “pyramid” approach toward one based upon early and sustained use of disease …

Objective. Trials of rheumatoid arthritis (RA) treatments report the average response in
multiple outcome measures for treated patients. It is more clinically relevant to test whether …

Objective Remission has become an attainable goal of rheumatoid arthritis (RA) treatment,
especially since the advent of biologic antirheumatic therapy. Because little is known about …

Objective. To develop a set of disease activity measures for use in rheumatoid arthritis (RA)
clinical trials, as well as to recommend specific methods for assessing each outcome …

Objective. To determine the discriminant validity of the core set of outcome measures
proposed by the American College of Rheumatology (ACR) and the Outcome Measures in …

Objective: To describe the frequency and duration of remission in the Utrecht rheumatoid
arthritis cohort of patients followed since diagnosis, and the clinical and treatment …

A composite index for estimating improvement in individual rheumatoid arthritis (RA)
patients during trials of slow‐acting, disease‐modifying antirheumatic drugs (DMARDs) was …

Background. Recent randomized controlled trials (RCTs) in rheumatoid arthritis (RA) have
used patient-and physician-reported outcomes, ESR and/or CRP as components of ACR …

It is standard practice to use multiple outcome measures in rheumatoid arthritis (RA) clinical
trials. Because of this, multiple testing is usually done, and there is confusion in the …